SABCS 2022 | Cardiovascular risk evaluation for breast cancer survivors: A pilot study

Ilana Schlam, MD, Tufts Medical Center, Boston, MA, provides an overview of a pilot study investigating the feasibility of performing cardiovascular risk evaluation for breast cancer survivors. The pilot study included 60 patients with breast cancer who had completed chemotherapy. Data was collected in terms of echocardiogram and other markers such as troponin and B-type natriuretic peptide (BNP) levels. Data was also collected on comorbidity factors such as diabetes, hypertension and obesity. The primary objective of the study was to describe the feasibility of performing a cardiovascular disease risk (CVD) assessment on breast cancer survivors. The study was conducted in a single center that was 80% Black patients, a patient population that has a higher CVD risk burden. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.